Mobile app to help teens and young adults with cancer manage stress
Official title: Pilot Trial Testing Mobile Health Psychosocial Intervention for Adolescents and Young Adults With Cancer
Run by Seattle Children's Hospital · NCT05842902 · Data updated 2026-11-12
This study tests a mobile app that helps teens and young adults with cancer manage stress and improve their mental health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 25 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Seattle Children's Hospital Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Seattle, Washington) |
| Status | Recruiting |
| Started | September 12, 2023 |
| Main results expected | August 1, 2027 |
| Study ends | August 1, 2027 |
| Registry record updated | August 3, 2026 |
| Trial ID | NCT05842902 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents and young adults aged 12-25 who have been diagnosed with a new malignancy and are undergoing chemotherapy or radiation therapy.
✕Probably not a fit
Patients with a cancer diagnosis older than 12 months or those receiving only surgical treatment may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot trial aims to evaluate the feasibility and acceptability of a mobile app called mPRISM, designed to assist adolescents and young adults with cancer in managing psychosocial symptoms. The app incorporates evidence-based strategies for stress management, goal-setting, and mindfulness. Participants will be randomly assigned to either receive the app immediately or be placed on a waitlist, allowing for a comparison of outcomes. The study focuses on improving quality of life and mental health among this vulnerable population.
Why it matters
Potential benefit: If successful, this app could significantly enhance the mental health and quality of life for young cancer patients.
How similar studies have gone: While mobile health interventions for psychosocial support are emerging, this specific approach using the mPRISM app is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 12-25 years * Diagnosis of new malignancy within 12 months of enrollment treated with chemotherapy and/or radiation therapy at Seattle Children's Hospital (SCH) * Patient able to speak/read/write English or Spanish language * Cognitively able to participate in mHealth psychosocial intervention and interactive interviews Exclusion Criteria: * Patient refusal to participate (any age), or parental refusal to participate for patients less than 18 years of age * Patients with diagnosis of malignancy \>12 months * Patients with relapsed, recurrent, or refractory disease * Patient without chemotherapy and/or radiation therapy as part of cancer treatment (e.g., surgical resection only patients are not-eligible) * Cognitively or physically unable to participate in mHealth psychosocial intervention and surveys
Where it's running
-
Seattle Children's Hospital
Seattle, Washington, United States Recruiting
Study contacts
- Study coordinator: Nancy Lau, PhD
- Email: nancy.lau@seattlechildrens.org
- Phone: 206-884-0569
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.